Causes of Guillain-Barré Syndrome
Guillain-Barré syndrome is primarily caused by preceding infections that trigger an autoimmune response, with Campylobacter jejuni being the most common infectious trigger worldwide, responsible for approximately one-third of all cases. 1
Primary Infectious Triggers
Bacterial Infections
- Campylobacter jejuni is the single most important trigger, causing gastroenteritis and food poisoning before GBS onset. Geographic variation exists: 60-70% of cases in regions like Curaçao, China, and Bangladesh versus 30-32% in other countries 1
- Mycoplasma pneumoniae (approximately 5% of cases) 1
- Haemophilus influenzae - particularly linked to Miller Fisher syndrome variant in Asia 1
Viral Infections
- Cytomegalovirus (10-13% of cases) 1
- Epstein-Barr virus (10% of cases) 1
- Zika virus - demonstrated 20-fold increase in GBS during French Polynesia outbreak (2013-2014), though only 2 in 10,000 infected individuals develop GBS 1
- Hepatitis E virus 2
- SARS-CoV-2 - reported association but epidemiological studies show no clear increase in GBS incidence during COVID-19 pandemic 1
- Other vector-borne viruses: chikungunya and dengue 1
- Enterovirus - linked to GBS outbreak in Peru (2018) 1
Temporal Pattern of Infection
Approximately two-thirds of patients report infectious symptoms within 4 weeks (some sources cite 6 weeks) before weakness onset 1, 2. The specific antecedent illness varies by geography:
- Europe, North America, South America, and parts of Asia: Upper respiratory tract infection most common (22-53% of cases; 50-70% in pediatric patients) 1
- India and Bangladesh: Gastroenteritis predominates (36-47% of cases) 1
Non-Infectious Triggers
Immunological Treatments (Rare)
- Vaccines: The 1976 "swine" influenza vaccine showed 7.3-fold increased risk. Modern influenza vaccines show minimal risk (approximately 1 additional case per million vaccinations) - several orders of magnitude lower than the 1976 vaccine. No other vaccines convincingly linked to GBS 2
- Immunobiologicals: TNF antagonists, immune checkpoint inhibitors, type I interferons (based on case series and biological plausibility) 2
Other Associations (Unclear Mechanism)
- Surgery and malignancy have temporal associations but lack clear biological rationale and strong epidemiological evidence 1, 2
Pathophysiological Mechanism
The underlying mechanism is molecular mimicry: infectious agents possess surface structures (particularly lipo-oligosaccharides in C. jejuni) that resemble human nerve gangliosides. This triggers cross-reactive antibodies that attack peripheral nerve components, causing demyelination and axonal degeneration 1. The immune response involves:
- Toll-like receptor-4 signaling activation
- Production of autoantibodies against gangliosides
- Complement activation leading to nerve damage
Critical Clinical Caveat
The absolute risk of developing GBS after infection is extremely low: only 1 in 1,000-5,000 patients with C. jejuni infection develop GBS within 2 months 1. This low conversion rate depends on:
- Specific C. jejuni strains with carbohydrate mimicry capability (not all strains possess this)
- Genetic polymorphisms (TNF gene, MBL2 gene) 1
- Nutritional status - malnutrition alters immune responses 1
- Host susceptibility factors
Important: Absence of antecedent illness does not exclude GBS diagnosis, as triggering infections or immunological stimuli can be subclinical 2.